Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030305 (
pancreatitis
)
16,014
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nitric oxide (NO) has been implicated to regulate pancreatic circulation, promote capillary integrity, and inhibit leukocyte adhesion. We investigated the role of NO in the development of
pancreatitis
.
Nitro-L-arginine
, an inhibitor of NO synthase, in total dose of 35 mg/kg body wt was infused in the rats with edematous
pancreatitis
induced by two intraperitoneal injections of cerulein (20 micrograms/kg). L-Arginine (125 or 250 mg/kg), a NO donor was intravenously administered twice in the rats with hemorrhagic
pancreatitis
induced by water-immersion stress plus two intraperitoneal injections of cerulein (40 micrograms/kg). The degree of pancreas edema, serum amylase levels, and histologic alterations were investigated.
Nitro-L-arginine
exacerbated cerulein-induced
pancreatitis
and caused a decrease in pancreatic blood flow. L-Arginine ameliorated the severity of hemorrhagic
pancreatitis
dose dependently and improved the pancreatic blood flow. These findings suggest that NO could confer protection against the development of hemorrhagic
pancreatitis
, probably through improvement of the pancreatic microcirculation.
...
PMID:Protective effect of nitric oxide on development of acute pancreatitis in rats. 758 83